Miguel AG / Boer M. Leishmaniasis Worldwide / Industrial Research / IMI / Leishmaniasis Worldwide / Council of Scientific / Developing Countries Clinical Trials Partnership / Sanofi / /
Continent
Africa / Asia / Europe / /
Country
Bangladesh / Iran / Sudan / Kenya / Uganda / Brazil / Paraguay / Ethiopia / Spain / India / /
Event
FDA Phase / Business Partnership / /
Facility
Institute of Endemic Diseases / PCR Capacity building / University of Caracas / Salpêtrière Hospital / Capacity building / /
IndustryTerm
blood bank / identified health technology gap / final products / healthcare / pharmaceutical / suggested health technology / development new tools / supporting tools / long-term sustainable solutions / therapeutic and diagnostic tools / healthcare philosophy / therapies for neglected tropical diseases / manufacturing / /
World Health Organization / Institute of Endemic Diseases / Council of Scientific and Industrial Research / Council of Scientific / Salpêtrière Hospital / Industrial Research / University of Caracas / European Union / /
Person
Kala Azar Dermal Leishmaniasis / /
Position
left end / /
Product
Global 1 R / Ambisome / amphotericin B / PoC / Projects1 / /
ProvinceOrState
Bihar / Georgia / /
PublishedMedium
PLoS ONE / policy Review / /
Region
East Africa / southern Europe / North Africa / Latin America / South Asia / South Sudan / Mediterranean / Middle-East / /